A detailed history of Rhenman & Partners Asset Management Ab transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 26,500 shares of MDGL stock, worth $5.75 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
26,500
Previous 36,500 27.4%
Holding current value
$5.75 Million
Previous $9.75 Million 23.83%
% of portfolio
0.73%
Previous 0.95%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$193.33 - $291.99 $1.93 Million - $2.92 Million
-10,000 Reduced 27.4%
26,500 $7.42 Million
Q1 2024

May 14, 2024

BUY
$171.37 - $283.23 $2.4 Million - $3.97 Million
14,000 Added 62.22%
36,500 $9.75 Million
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $2.71 Million - $5.34 Million
22,500 New
22,500 $5.21 Million
Q4 2019

Jan 17, 2020

SELL
$84.28 - $118.5 $2.53 Million - $3.56 Million
-30,000 Closed
0 $0
Q3 2019

Oct 16, 2019

SELL
$84.4 - $106.53 $609,790 - $769,679
-7,225 Reduced 19.41%
30,000 $2.59 Million
Q2 2019

Jul 22, 2019

BUY
$91.13 - $142.5 $911,300 - $1.43 Million
10,000 Added 36.73%
37,225 $3.9 Million
Q1 2019

Apr 11, 2019

BUY
$103.48 - $143.84 $2.82 Million - $3.92 Million
27,225 New
27,225 $3.41 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.